CGON logo

CG Oncology, Inc. (CGON) Cash From Financing

Annual CFF:

$628.28M+$541.28M(+622.18%)
December 31, 2024

Summary

  • As of today, CGON annual cash from financing is $628.28 million, with the most recent change of +$541.28 million (+622.18%) on December 31, 2024.
  • During the last 3 years, CGON annual cash from financing has risen by +$612.83 million (+3967.58%).
  • CGON annual cash from financing is now at all-time high.

Performance

1-Year Change

+622.18%

3-Year Change

+3967.58%

5-Year Change

+3967.58%

15-Year Change

+3967.58%

CGON Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

97.89%
CGON annual cash from financing is higher than 97.89% of companies in Healthcare sector

Range

All-Time High

$628.28M
CGON annual cash from financing is currently at an all-time high

3-Year Low

$15.45M
CGON annual cash from financing is currently +3967.58% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
CGON previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

Mar 26, 2026
CGON next annual earnings announcement is scheduled for Mar 26, 2026

OtherCGONcash flow metrics

Annual CFI

-$300.76M
CGON annual cash from investing is -$300.76 million

Annual CFO

-$78.71M
CGON annual cash from operations is -$78.71 million

Annual FCF

-$78.95M
CGON annual free cash flow is -$78.95 million

Annual CAPEX

$234.00K
CGON annual capital expenditures is $234.00 thousand

Quarterly CFF:

$54.37M+$54.67M(+18468.24%)
September 30, 2025

Summary

  • As of today, CGON quarterly cash from financing is $54.37 million, with the most recent change of +$54.67 million (+18468.24%) on September 30, 2025.
  • Over the past year, CGON quarterly cash from financing has increased by +$52.20 million (+2409.00%).
  • CGON quarterly cash from financing is now -86.50% below its all-time high of $402.66 million, reached on March 31, 2024.

Performance

3-Month Change

+18468.24%

1-Year Change

+2409%

3-Year Change

-

5-Year Change

-

CGON Quarterly Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

91.97%
CGON quarterly cash from financing is higher than 91.97% of companies in Healthcare sector

Range

All-Time High

$402.66M
CGON quarterly cash from financing is currently -86.50% below its historical high of $402.66 million

3-Year Low

-$15.22M
CGON quarterly cash from financing is currently +457.11% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
CGON previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Mar 26, 2026
CGON next earnings announcement is scheduled for Mar 26, 2026

OtherCGONcash flow metrics

Quarterly CFI

$15.04M
CGON quarterly cash from investing is $15.04 million

Quarterly CFO

-$38.89M
CGON quarterly cash from operations is -$38.89 million

Quarterly FCF

-$38.99M
CGON quarterly free cash flow is -$38.99 million

Quarterly CAPEX

$97.00K
CGON quarterly capital expenditures is $97.00 thousand

TTM CFF:

$277.94M+$52.20M(+23.13%)
September 30, 2025

Summary

  • As of today, CGON TTM cash from financing is $277.94 million, with the most recent change of +$52.20 million (+23.13%) on September 30, 2025.
  • Over the past year, CGON TTM cash from financing has dropped by -$126.93 million (-31.35%).
  • CGON TTM cash from financing is now -55.76% below its all-time high of $628.28 million, reached on December 31, 2024.

Performance

3-Month Change

+23.13%

1-Year Change

-31.35%

3-Year Change

-

5-Year Change

-

CGON TTM Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

95.13%
CGON TTM cash from financing is higher than 95.13% of companies in Healthcare sector

Range

All-Time High

$628.28M
CGON TTM cash from financing is currently -55.76% below its historical high of $628.28 million

3-Year Low

-$15.99M
CGON TTM cash from financing is currently +1838.20% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
CGON previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Mar 26, 2026
CGON next earnings announcement is scheduled for Mar 26, 2026

OtherCGONcash flow metrics

TTM CFI

-$159.41M
CGON TTM cash from investing is -$159.41 million

TTM CFO

-$116.79M
CGON TTM cash from operations is -$116.79 million

TTM FCF

-$117.13M
CGON TTM free cash flow is -$117.13 million

TTM CAPEX

$336.00K
CGON TTM capital expenditures is $336.00 thousand

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

CGON Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+622.2%+2409.0%-31.4%
3Y3 Years+3967.6%--
5Y5 Years+3967.6%--

CGON Cash From Financing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+3967.6%-86.5%+457.1%-55.8%+1838.2%
5Y5-Yearat high+3967.6%-86.5%+457.1%-55.8%+1838.2%
All-TimeAll-Timeat high+3967.6%-86.5%+457.1%-55.8%+1838.2%

CGON Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2025
-
$54.37M(>+9900.0%)
$277.94M(+23.1%)
Jun 2025
-
-$296.00K(-165.8%)
$225.74M(-0.1%)
Mar 2025
-
$450.00K(-99.8%)
$226.07M(-64.0%)
Dec 2024
$628.28M
$223.41M(>+9900.0%)
$628.28M(+55.2%)
Sep 2024
-
$2.17M(+5317.5%)
$404.87M(+0.5%)
Jun 2024
-
$40.00K(-100.0%)
$402.70M(+3.9%)
DateAnnualQuarterlyTTM
Mar 2024
-
$402.66M(+2744.7%)
$387.43M(+2523.0%)
Dec 2023
$87.00M(-27.3%)
-
-
Jun 2023
-
-$15.22M(-1890.2%)
-$15.99M(-1990.2%)
Mar 2023
-
-$765.00K
-$765.00K
Dec 2022
$119.69M(+674.9%)
-
-
Dec 2021
$15.45M
-
-

FAQ

  • What is CG Oncology, Inc. annual cash from financing?
  • What is the all-time high annual cash from financing for CG Oncology, Inc.?
  • What is CG Oncology, Inc. annual cash from financing year-on-year change?
  • What is CG Oncology, Inc. quarterly cash from financing?
  • What is the all-time high quarterly cash from financing for CG Oncology, Inc.?
  • What is CG Oncology, Inc. quarterly cash from financing year-on-year change?
  • What is CG Oncology, Inc. TTM cash from financing?
  • What is the all-time high TTM cash from financing for CG Oncology, Inc.?
  • What is CG Oncology, Inc. TTM cash from financing year-on-year change?

What is CG Oncology, Inc. annual cash from financing?

The current annual cash from financing of CGON is $628.28M

What is the all-time high annual cash from financing for CG Oncology, Inc.?

CG Oncology, Inc. all-time high annual cash from financing is $628.28M

What is CG Oncology, Inc. annual cash from financing year-on-year change?

Over the past year, CGON annual cash from financing has changed by +$541.28M (+622.18%)

What is CG Oncology, Inc. quarterly cash from financing?

The current quarterly cash from financing of CGON is $54.37M

What is the all-time high quarterly cash from financing for CG Oncology, Inc.?

CG Oncology, Inc. all-time high quarterly cash from financing is $402.66M

What is CG Oncology, Inc. quarterly cash from financing year-on-year change?

Over the past year, CGON quarterly cash from financing has changed by +$52.20M (+2409.00%)

What is CG Oncology, Inc. TTM cash from financing?

The current TTM cash from financing of CGON is $277.94M

What is the all-time high TTM cash from financing for CG Oncology, Inc.?

CG Oncology, Inc. all-time high TTM cash from financing is $628.28M

What is CG Oncology, Inc. TTM cash from financing year-on-year change?

Over the past year, CGON TTM cash from financing has changed by -$126.93M (-31.35%)
On this page